6. Navigating Surgery • Dr. Julie Hallet • Sunnybrook Health Sciences Centre • 2026 Conference
In this session from the Neuroendocrine Cancer Foundation’s 2026 Virtual Annual Patient Conference, Dr. Julie Hallet, surgical oncologist and associate professor of surgery at Sunnybrook Health Sciences Centre and the University of Toronto, presents “Navigating Surgery for Neuroendocrine Tumors.” Dr. Hallet explains how surgery may be considered across the neuroendocrine tumor care journey, from local regional disease to metastatic disease and recurrence. She discusses when surgery may be used with curative intent, when it may help provide long-term disease control or symptom relief, and why treatment decisions should be tailored to the tumor type, disease extent, tumor biology, symptoms, and each patient’s goals. This presentation also covers topics such as small pancreas neuroendocrine tumors that may be safely monitored, mesenteric-sparing surgery for small bowel NETs, surgery for liver metastases, carcinoid syndrome considerations, preoperative preparation, postoperative recovery, long-term monitoring, quality of life, and the importance of receiving care from a multidisciplinary neuroendocrine tumor team. Learn more about the Neuroendocrine Cancer Foundation and access patient resources at www.NCF.net.
In this session from the Neuroendocrine Cancer Foundation’s 2026 Virtual Annual Patient Conference, Dr. Julie Hallet, surgical oncologist and associate professor of surgery at Sunnybrook Health Sciences Centre and the University of Toronto, presents “Navigating Surgery for Neuroendocrine Tumors.” Dr. Hallet explains how surgery may be considered across the neuroendocrine tumor care journey, from local regional disease to metastatic disease and recurrence. She discusses when surgery may be used with curative intent, when it may help provide long-term disease control or symptom relief, and why treatment decisions should be tailored to the tumor type, disease extent, tumor biology, symptoms, and each patient’s goals. This presentation also covers topics such as small pancreas neuroendocrine tumors that may be safely monitored, mesenteric-sparing surgery for small bowel NETs, surgery for liver metastases, carcinoid syndrome considerations, preoperative preparation, postoperative recovery, long-term monitoring, quality of life, and the importance of receiving care from a multidisciplinary neuroendocrine tumor team. Learn more about the Neuroendocrine Cancer Foundation and access patient resources at www.NCF.net.